BMJ Editorial: Dexamethasone in the management of covid -19

Editorial discusses preliminary findings of RECOVERY trial which reported lower mortality rate with dexamethasone vs standard care in patients with severe COVID-19. It notes neither, optimal dose, duration, nor timing were explored, and risks in older patients remain unclear.


British Medical Journal